Urinary Cytology. Spasenija Savic Prince, MD Pathology, University Hospital Basel, Switzerland

Similar documents
Urinary Cytology. Spasenija Savic Prince Pathology, University Hospital Basel, Switzerland

Rationale of The Paris System for Reporting Urinary Cytopathology: The NEW paradigm

Toyonori Tsuzuki MD, PhD Professor and Chair Department of Surgical Pathology Aichi Medical University Hospital

The application of cytology in urological diseases

Afterword: The Paris System for Reporting Urinary Cytology

Application of Urovision FISH testing for diagnosis of bladder cancer

Index 179. Genital tract contaminants, 17, 20, 22, 150 papilloma virus-infected cells, 47 squamous cells, sources of, 7

Prepared By Jocelyn Palao and Layla Faqih

Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology A Correlative Study of 124 Cases

Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

BLADDER CANCER EPIDEMIOLOGY

URINE CYTOLOGY. Richard Doughty Avd for patologi Ahus

PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals

Normal Morphology. Anatomic Considerations. Normal Urothelial Histology and Cytology

BOSNIAN-TURKISH CYTOPATHOLOGY SCHOOL June 18-19, 2016 Sarajevo. Case Discussions. 60 year old woman Routine gynecologic control LBC

Cytyc Corporation - Case Presentation Archive - October 2001

A novel urine cytology stain for the detection and monitoring of urothelial carcinoma

Transitional Cell Carcinoma of the Renal Pelvis The Diagnostic Role of Pelvic Washings

SQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H)

40th European Congress of Cytology Liverpool, UK, 2-5 th October 2016

Proliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London

Thyroid follicular neoplasms in cytology. Ulrika Klopčič Institute of Oncology, Department of Cytopathology, Ljubljana, Slovenia

Cytyc Corporation - Case Presentation Archive - March 2002

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.

American Society of Cytopathology Core Curriculum in Molecular Biology

Synonyms. Nephrogenic metaplasia Mesonephric adenoma


Urinary Bladder: WHO Classification and AJCC Staging Update 2017

Combining Color and Morphology Improves Identification of Low-Grade Urothelial Cancer Cells

Thyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS

ACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation

Evaluation of Breast Specimens Removed by Needle Localization Technique

Award Top Quizzes For Residents

LGM International, Inc.

Thyroid master class. Thyroid Fine needle aspiration cytology and liquid-based techniques: Hologic and Becton Dickinson

04/09/2018. Squamous Cell Neoplasia and Precursor Lesions. Agenda. Squamous Dysplasia. Squamo-proliferative lesions. Architectural features

Biliary Tract Neoplasia: A Cyto-histologic Review. Michelle Reid, MD, MSc Professor of Pathology Director of Cytopathology Emory University Hospital

Hyperchromatic Crowded Groups: What is Your Diagnosis? Session 3000

FNA of Thyroid. Toward a Uniform Terminology With Management Guidelines. NCI NCI Thyroid FNA State of the Science Conference

Respiratory Tract Cytology

Gynecologic Cytopathology: Glandular lesions

Staging and Grading Last Updated Friday, 14 November 2008

Salivary Gland Cytology: A Clinical Approach to Diagnosis and Management of Atypical and Suspicious Lesions

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

Accuracy of Urine Cytology and the Significance of an Atypical Category

Introduction. 23 rd Annual Seminar in Pathology. FLUIDS, Part 1. Pittsburgh, PA Gladwyn Leiman UVMMC, VT

Kidney, Bladder and Prostate Neoplasia. David Bingham MD

Villoglandular adenocarcinoma of cervix a tumour with bland cytological features: report of a case missed on cytology

Morphology I Slide: 1

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES

CINtec p16 INK4a Staining Atlas

Case # year old man with a 2 cm right kidney mass

Salivary Gland Cytology

Pathology of bladder cancer in Egypt; a current study.

Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016

Pancreatic malignant tumors are the fifth leading cause of cancerrelated

Almost any suspected tumor can be aspirated easily and safely. Some masses are more risky to aspirate including:

Mody. AIS vs. Invasive Adenocarcinoma of the Cervix

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case

"Atypical": Criteria and

Ascitic Fluid and Use of Immunocytochemistry. Mercè Jordà, University of Miami

Introduction 10/27/2011. Follicular Lesion/Atypia of Undetermined Significance

Papillary Lesions of the breast

Medullary Thyroid Carcinoma. This case was provided by Treant Hospital, Bethesda, Hoogeveen, The Netherlands

Predictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin

Demystifying Endometrial Hyperplasia

Outline 11/2/2017. Pancreatic EUS-FNA general aspects. Cytomorphologic features of solid neoplasms/lesions of the pancreas

Cytyc Corporation - Case Presentation Archive - July 2002

Spectrum of Lesions in Cystoscopic Bladder Biopsies -A Histopathological Study

Cytology Report Format

형태계측학적분석과 ThinPrep 액상소변세포검사를이용한악성요로상피세포검출

International Journal of Pharma and Bio Sciences CHROMOPHOBE VARIANT OF RENAL CELL CARCINOMA MASQUARDING AS RENAL ONCOCYTOMA ON CYTOLOGY.

Case 1. Slide 1 History: 65 year old male presents with bilateral pleural effusions, a 40 pack year smoking history and peripheral and hilar lung

DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES

Good afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting

New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology

Serous Effusions. Spasenija Savic Prince, MD Pathology, University Hospital Basel, Switzerland

Controversies in the management of Non-muscle invasive bladder cancer

G3.02 The malignant potential of the neoplasm should be recorded. CG3.02a

BLADDER CANCER: PATIENT INFORMATION

Pathologic Assessment of Invasion in TUR Specimens. A. Lopez-Beltran. T1 (ct1)

The role of the cytologist in breast cancer screening

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase

How Many Diseases in Carcinoma in situ?

AP110 URINARY BLADDER BIOPSY INTERPRETATION Part 1

Papillary Lesions of the Breast: WHO Update

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.

Histopathology: skin pathology

Cytoplasmic changes Nuclear changes

A NOVEL URINE CYTOLOGY STAIN FOR THE DETECTION AND MONITORING OF UROTHELIAL CARCINOMA. Running head: A Novel Stain For The Detection Of Bladder Cancer

Potential Pitfalls for False Suspicion of Papillary Thyroid Carcinoma:

Morphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens

Epithelial Columnar Breast Lesions: Histopathology and Molecular Markers

Maturation Index 3/29/2017. Disclosure of Relevant Financial Relationships. Gynecologic Cytology. Normal Maturation of Squamous Epithelium : :

Transcription:

Urinary Cytology Spasenija Savic Prince, MD Pathology, University Hospital Basel, Switzerland

Outline Pre-analytics The Paris System (TPS): Background Diagnostic categories Morphologic criteria for each category Ancillary FISH testing Examples

Urinary Specimens: Collection, preservation and processing Urine Randomly voided Forced diuresis Catheter Ileum conduit Washings Bladder, UUT 50-100ml

Time to processing: at RT: 4h at 4 C: 24h with preservation ( fixation) 50% ethanol 1:1: 48h native 50% ethanol 1:1

Cytospin PAP 7mm coated glass slide

Cystoscopy Urinary Cytology & false neg. in -30% invasive long-term surveillance: expensive cheap high spec. for high-grade UC non-visible high-grade UC no universal classification system equivocal atypia low sens. for low-grade UC

Low grade Lesions High grade Lesions Cells look benign Rarely shed Rarely invade Rarely kill Cells are UGLY Cells shed singly Often invade Often lethal

nuclear / cytologic atypia mild moderate severe (G3)

Nuclear / cytologic atypia low moderate/high certain Probability of high-grade UC

Nuclear / cytologic atypia PPV >90% low moderate/high certain Probability of high-grade UC

Distribution of diagnostic categories utilized in The Paris System survey (unpublished data) Total range Academic Private Practice Positive 1.0 6.3% 1.2 4.9% Suspicious 0.7 5.4% 0.2 2.7% Atypical 1.8 23.7% 3.1 21.4% Negative 75.4 94.8% 71.4 96.1% Washing 1.0 74% 1.0 22.2% Number/year 841 9210 81-4932 Rosenthal DL

Nuclear / cytologic atypia PPV? >90% low moderate/high certain Probability of high-grade UC

International online Quiz on Urinary cytology 246 participants; 52 cases, mostly difficult http://kathrin.unibas.ch/urinzyto/loesung/ Glatz K. et al. Am J Clin Pathol. 2006

International online Quiz on Urinary cytology 246 participants; 52 cases, mostly difficult 29 (!) classification systems http://kathrin.unibas.ch/urinzyto/loesung/ Glatz K. et al. Am J Clin Pathol. 2006

FISH neg; Cystoscopy inconspicious y male with hematuria

58 jg. Mann mit Hämaturie FISH neg; Zystoskopie unauffällig 48.8% false positive

ASC 2013 ICC Paris, May 2013 ASC 2014 USCAP 2014 ECC, Geneva, 2014

The Paris System for Reporting Urinary Cytology 2013 - IAC International Congress of Cytology in Paris ASC and IAC agreed to support TPS Working Group by establishing Websites to invite comments from members 2014 - Website Statements went live in Spring, translated into Japanese, Chinese and Korean 2016 - Springer Publishers to produce The Paris System for Reporting Urinary Cytology in the same format as The Bethesda System

Goal of The Paris System: FIND THE HIGH-GRADE CANCERS 1st ed. 2016, XV, 220 p. 101 illus., 97 illus. in color

Diagnostic Categories of TPS Negative for HGUC: negative Atypical Urothelial Cells: AUC Suspicious for HGUC: SHGUC High Grade Urothelial Carcinoma: HGUC Low Grade Urothelial Neoplasia: LGUN Other malignancies Primary/secondary

Relative Risk of the Diagnostic Categories Outlined in the Paris System, Based on Studies to Date: Barkan GA et al, Acta Cytol 2016; 60:185-197

Negative for HGUC (Negative) Benign/reactive urothelial & other epithelial cells Benign urothelial fragments and sheets or clusters Changes associated with lithiasis Viral cytopathic effects (e.g. Decoy cells) Post-therapy effect (BCG, chemoth., Rx)

Reactive changes Irritative bladder Post-BCG

Mitomycin effect Reactive changes

Urothelial Fragments: Papillary-like cell clusters (washings and voided urine) Z05.21169_neg Benign

High Grade Urothelial Carcinoma Histopathologic definition: Non-invasive papillary urothelial carcinoma Moderate to marked architectural and cytologic atypia Urothelial carcinoma in situ Flat lesion with cytologically malignant cells Invasive urothelial carcinoma Invasion beyond the basement membrane WHO, 2015

HGUC (1-6%; gross hematuria: 20%) Diagnostic work-up Tis Ta T1 pt2 TUR + intravesical Treatment Cystectomy Lifelong follow-up Babjuk M Eur Urol. 2013

Morphologic criteria: High Grade Urothelial Carcinoma Non-superficial and non-degenerated urothelial cells with N/C ratio of 0.7 Nuclear hyperchromasia, moderate severe Marked irregular nuclear membranes: shape and thickness Irregular, coarse, clumped chromatin Minimum of 5-10 viable malignant cells

Other features: High Grade Urothelial Carcinoma Cellular pleomorphism: Look for the BIG cells Marked variation in cellular size and shapes Malignant cells may be oval, rounded, elongated, or plasmacytoid (Comet cells) Scant, pale or dense cytoplasm Prominent nucleoli Mitoses Necrotic debris Inflammation

5-seconds rule

HGUC G3

HGUC Carcinoma in situ

WHO 1973 G1 G2 G3 WHO 2004/15 Low grade High grade

WHO 1973 G1 G2 G3 WHO 2004/15 Low grade High grade

Diagnostic Categories of TPS Negative for HGUC: negative Atypical Urothelial Cells: AUC Suspicious for HGUC: SHGUC High Grade Urothelial Carcinoma: HGUC Low Grade Urothelial Neoplasia: LGUN Other malignancies Primary/secondary

Suspicious for High Grade Urothelial Carcinoma Definition: Urothelial cells with severe atypia that quantitatively fall short of a diagnosis of HGUC and are beyond atypia of the AUC category

Morphologic criteria: Suspicious for High Grade Urothelial Carcinoma Major criterion (required) Non-superficial and non-degenerated urothelial cells with N/C ratio of 0.5-0.7 Nuclear hyperchromasia, moderate - severe Minor criterion (at least one required) Marked irregular nuclear membranes: shape and thickness Irregular, coarse, clumped chromatin Cells of HGUC but only <5 (-10)

Suspicious for HGUC Biopsy: CIS

Atypical Urothelial Cells The Goal for the AUC category is to capture the cases worrisome for HGUC that fall short of the suspicious for HGUC category

Atypical Urothelial Cells Urothelial cells with mild to moderate cytological (not architectural) atypia Degenerated cells of uncertain atypia Requires exclusion of changes in which the reason for atypia is evident: reactive urothelial cells, urothelial clusters (tissue fragments), post-therapy effects, decoy cells

Morphologic criteria: Atypical Urothelial Cells Major criterion (required) Non-superficial urothelial cells with N/C ratio of >0.5 Minor criterion (one required) Nuclear hyperchromasia, mild - moderate Irregular nuclear membranes: shape and thickness Irregular, coarse, clumped chromatin

Degenerative atypia Z03.21445 Z04.21868 Z04.21868

AUC Pelvic washing Vacuolar changes of the cytoplams: in favor of benign

What about LGUC? Cells look benign Rarely shed Rarely invade Rarely kill

What about LGUC? Cells look benign Rarely shed Rarely invade Rarely kill LG urothelial NEOPLASIA: Urothelial papilloma PUNLMP LGPUC

True papillae Morphologic criteria: Low-Grade Urothelial Neoplasia Three-dimensional cellular papillary clusters with fibrovascular cores including capillaries definitive cytologic diagnosis of LGPUN

Morphologic criteria: Low-Grade Urothelial Neoplasia Monotonous single (non-umbrella) cell pattern: G1-G2: N/C ratio, nuclear border irregularities, cytoplasmic homogeneity DD LGUN correlation with cystoscopy categorized as "Negative for HGUC with a note

LGUN pta, G2, low-grade

Negative for HGUC Comment: Suggestive of LGUN

Negative for HGUC Comment: Suggestive of LGUN

Morphological aspects not considered for know Monotony of the cell image Nucleoli Mitoses Excentric position of the nuclei Quality of the cytoplasm Vacuolisation Perinuclear clearing

Paris Reporting: Examples Bladder washing: Decoy cells (6/10 HPF). Paris: NHGUC (negativ für high grade UC) Voided urine: Urothelial cells with not classifiable nuclear atypia. Paris: AUC (atypical urothelial cells) Bladder washing: Numerous urothelial cells with severe nuclear atypia (G3). Paris: HGUC (high grade Urothelkarzinom)